MEZOVITY Trademark

Trademark Overview

On Friday, March 24, 2017, a trademark application was filed for MEZOVITY with the United States Patent and Trademark Office. The USPTO has given the MEZOVITY trademark a serial number of 87384640. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 28, 2025. This trademark is owned by Bayer Aktiengesellschaft. The MEZOVITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
mezovity

General Information

Serial Number87384640
Word MarkMEZOVITY
Filing DateFriday, March 24, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 28, 2025
Registration Number5538259
Registration DateTuesday, August 14, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Aktiengesellschaft
Party Type30 - Original Registrant
Legal Entity Type99 - Other
Address51373 Leverkusen
DE
Party NameBayer Aktiengesellschaft
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address51373 Leverkusen
DE
Party NameBayer Aktiengesellschaft
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address51373 Leverkusen
DE

Trademark Events

Event DateEvent Description
Saturday, June 17, 2017LETTER OF SUSPENSION E-MAILED
Tuesday, March 28, 2017NEW APPLICATION ENTERED
Wednesday, March 29, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 17, 2017ASSIGNED TO EXAMINER
Saturday, June 17, 2017SUSPENSION LETTER WRITTEN
Saturday, June 17, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 17, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 23, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 2, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, October 15, 2017ASSIGNED TO LIE
Tuesday, October 17, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 17, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 28, 2017PUBLISHED FOR OPPOSITION
Tuesday, November 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 10, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 14, 2018REGISTERED-PRINCIPAL REGISTER
Monday, August 14, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, February 28, 2025CANCELLED SEC. 8 (6-YR)
Tuesday, July 10, 20181(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, February 16, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 16, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 5, 2018TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, June 5, 2018NOTICE OF ALLOWANCE CANCELLED

Related Keywords

mezovity cancer treatment preparations pharmaceutical